Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
United States | Publication | November 17, 2021
On November 17, the Judicial Panel on Multidistrict Litigation selected by lottery the Court of Appeals for the Sixth Circuit to hear the 34 now-consolidated challenges lodged against OSHA's Emergency Temporary Standard (ETS) "vaccine-or-test" mandate. The Sixth Circuit will conduct further proceedings involving the various constitutional and other procedural and substantive challenges filed in the multiple circuits, presumably including ruling on petitioners' requests for a temporary and permanent injunction against implementation and enforcement of the ETS.
It is unknown presently whether the Sixth Circuit will entertain any motion to dissolve the stay ordered against the ETS by the Fifth Circuit. OSHA has stated it is complying with the stay.
As announced today, the ETS is also facing a challenge sponsored by all 50 Senate Republicans and 160 House Republicans under the Congressional Review Act (CRA). The CRA permits either or both Congressional chambers to pursue a joint resolution of disapproval which would invalidate the mandate if the resolution is passed by both the House and Senate and is signed by the President, or if Congress successfully overrides a presidential veto.
Special thanks to law clerk Michelle Avidisyans (Los Angeles) for her assistance in the preparation of this content.
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
The ongoing conflicts and further geopolitical tensions in Eastern Europe and the Middle East, coupled with upcoming elections in a number of key countries including the US and the UK, make 2024 challenging to predict what impact this will have on the insurance sector.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023